Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New COVID booster shows promise in trial

NCT ID NCT06181292

First seen Mar 21, 2026 · Last updated May 24, 2026 · Updated 11 times

Summary

This study tested a new booster vaccine for COVID-19 in 913 adults who had already received initial vaccines and at least one booster. The goal was to see if the new booster is safe and triggers a strong immune response against newer virus variants. Participants received either the new vaccine or an existing one, and researchers compared side effects and antibody levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SARS-COV2 INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • CAP Centelles

    Centelles, Barcelona, 08540, Spain

  • Hospital Clínico Universitario de Valencia

    Valencia, Valencia, 46010, Spain

  • Hospital Germans Trias i Pujol

    Badalona, Barcelona, 08916, Spain

  • Hospital HM Delfos

    Barcelona, Barcelona, 08023, Spain

  • Hospital HM Puerta del Sur

    Móstoles, Madrid, 28938, Spain

  • Hospital HM Sanchinarro

    Madrid, Madrid, 28050, Spain

  • Hospital Josep Trueta

    Girona, Girona, 17001, Spain

  • Hospital Quironsalud Madrid

    Madrid, Madrid, 28223, Spain

  • Hospital Regional de Málaga

    Málaga, Málaga, 29010, Spain

  • Hospital Universitario de Cruces

    Barakaldo, Vizcaya, 48903, Spain

Conditions

Explore the condition pages connected to this study.